Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.19 USD | +1.55% | +7.47% | +7.31% |
Sales 2024 * | 801M 64.12B | Sales 2025 * | 858M 68.67B | Capitalization | 2.7B 216B |
---|---|---|---|---|---|
Net income 2024 * | 47M 3.76B | Net income 2025 * | 85M 6.8B | EV / Sales 2024 * | 3.24 x |
Net cash position 2024 * | 97.9M 7.84B | Net cash position 2025 * | 382M 30.58B | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
88.6
x | P/E ratio 2025 * |
41.5
x | Employees | 694 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 20.12% |
Latest transcript on GoodRx Holdings, Inc.
1 day | +1.55% | ||
1 week | +7.47% | ||
Current month | +1.27% | ||
1 month | +1.84% | ||
3 months | +10.79% | ||
6 months | +37.21% | ||
Current year | +7.31% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Wagner
CEO | Chief Executive Officer | 53 | 24/04/23 |
Trevor Bezdek
FOU | Founder | 46 | 31/08/11 |
Douglas Hirsch
FOU | Founder | 53 | 31/08/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Agnes Rey-Giraud
BRD | Director/Board Member | 59 | 31/05/16 |
Dipanjan Deb
BRD | Director/Board Member | 54 | 30/09/15 |
Greg Mondre
BRD | Director/Board Member | 49 | 30/09/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.23% | 9 M€ | +22.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 7.19 | +1.55% | 938,229 |
25/04/24 | 7.08 | +1.72% | 558,378 |
24/04/24 | 6.96 | -0.14% | 803,587 |
23/04/24 | 6.97 | +4.65% | 1,115,408 |
22/04/24 | 6.66 | -0.45% | 404,235 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.31% | 2.7B | |
+18.66% | 414B | |
+15.27% | 242B | |
+12.15% | 144B | |
+20.63% | 104B | |
+17.19% | 83.87B | |
+54.11% | 57.64B | |
+33.59% | 53.37B | |
+6.02% | 37.83B | |
+15.88% | 32.51B |
- Stock Market
- Equities
- GDRX Stock